Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 85 /hr
Hire Dr. Yosif E.
Japan
USD 85 /hr

Medical doctor and strong research professional with a PhD focused on Tumor Immunology and Cell Therapy

Profile Summary
Subject Matter Expertise
Services
Writing Technical Writing
Research Gray Literature Search, Systematic Literature Review, Secondary Data Collection
Product Development Formulation
Work Experience

PostDoc

National Center of Neurology and Psychiatry

September 2018 - Present

PostDoc

Hyogo College of Medicine

April 2018 - Present

Education

PhD

Hyogo College of Medicine

April 2013 - August 2018

MD

Medical University of Sofia

September 2005 - December 2012

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
(2019). Upregulation of Natural Killer Cells Proliferation by Cytokine Stimulation . Monoclonal antibodies in immunodiagnosis and immunotherapy.
(2018). Physiological and molecular effects of interleukin-18 administration on the mouse kidney . Journal of Translational Medicine. 16. (1). p. 51.
(2017). Interleukin-18 and testosterone levels in men with metabolic syndrome . The Aging Male. p. 1--8. Informa {UK} Limited
(2017). Interleukin-18 serum level is elevated in type 2 diabetes and latent autoimmune diabetes . Endocrine Connections. p. EC--17--0273. {BioScientifica}
(2016). Dysfunction of mitochondria and deformed gap junctions in the heart of IL-18-deficient mice . American Journal of Physiology-Heart and Circulatory Physiology. 311. (2). p. H313--H325. American Physiological Society
(2016). Augmentation of immune checkpoint cancer immunotherapy with IL18 . Clinical Cancer Research. 22. (12). p. 2969-2980.